Request Deal Involvement
SAB Biotherapeutics went public via a SPAC merger with Big Cypress Acquisition in a c.$325m deal.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Lazard
legal advisors
Stradling Yocca Carlson & Rauth
pr advisors
BLL Partners
financial advisors
Chardan
financial advisors
Brookline Capital
legal advisors
Dentons
financial advisors
Ladenburg Thalmann
or
Principals
target
SAB BIOTHERAPEUTICS INC
bidder
BIG CYPRESS ACQUISITION CORP
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite